chr12-118172617-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_016281.4(TAOK3):āc.1739A>Gā(p.Glu580Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000731 in 1,614,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00016 ( 0 hom., cov: 32)
Exomes š: 0.000064 ( 0 hom. )
Consequence
TAOK3
NM_016281.4 missense
NM_016281.4 missense
Scores
3
3
13
Clinical Significance
Conservation
PhyloP100: 8.02
Genes affected
TAOK3 (HGNC:18133): (TAO kinase 3) The protein encoded by this gene is a serine/threonine protein kinase that activates the p38/MAPK14 stress-activated MAPK cascade but inhibits the basal activity of the MAPK8/JNK cascade. The encoded protein is a member of the GCK subfamily of STE20-like kinases. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.27142006).
BS2
High AC in GnomAd4 at 25 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAOK3 | NM_016281.4 | c.1739A>G | p.Glu580Gly | missense_variant | 17/21 | ENST00000392533.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAOK3 | ENST00000392533.8 | c.1739A>G | p.Glu580Gly | missense_variant | 17/21 | 1 | NM_016281.4 | P1 | |
TAOK3 | ENST00000419821.6 | c.1739A>G | p.Glu580Gly | missense_variant | 17/21 | 1 | P1 | ||
TAOK3 | ENST00000537952.1 | c.359A>G | p.Glu120Gly | missense_variant | 4/8 | 2 | |||
TAOK3 | ENST00000537305.5 | n.2420A>G | non_coding_transcript_exon_variant | 14/18 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152226Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
25
AN:
152226
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000191 AC: 48AN: 251468Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135906
GnomAD3 exomes
AF:
AC:
48
AN:
251468
Hom.:
AF XY:
AC XY:
18
AN XY:
135906
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000636 AC: 93AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.0000605 AC XY: 44AN XY: 727244
GnomAD4 exome
AF:
AC:
93
AN:
1461890
Hom.:
Cov.:
31
AF XY:
AC XY:
44
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000164 AC: 25AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74378
GnomAD4 genome
AF:
AC:
25
AN:
152226
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74378
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2022 | The c.1739A>G (p.E580G) alteration is located in exon 17 (coding exon 15) of the TAOK3 gene. This alteration results from a A to G substitution at nucleotide position 1739, causing the glutamic acid (E) at amino acid position 580 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;B;.
Vest4
MutPred
Gain of catalytic residue at I582 (P = 0.0165);Gain of catalytic residue at I582 (P = 0.0165);.;
MVP
MPC
1.2
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at